Nisa Investment Advisors’s Tandem Diabetes Care TNDM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$18.7K Sell
1,237
-1,545
-56% -$27K ﹤0.01% 2250
2026
Q1
$53.3K Buy
2,782
+1,447
+108% +$31.4K ﹤0.01% 1640
2025
Q4
$29.3K Buy
1,335
+440
+49% +$7.94K ﹤0.01% 1798
2025
Q3
$10.9K Sell
895
-3,276
-79% -$44.3K ﹤0.01% 2250
2025
Q2
$77.7K Buy
4,171
+2,717
+187% +$53.8K ﹤0.01% 1476
2025
Q1
$27.9K Buy
1,454
+163
+13% +$4.77K ﹤0.01% 1762
2024
Q4
$46.5K Sell
1,291
-4,559
-78% -$154K ﹤0.01% 1700
2024
Q3
$248K Sell
5,850
-86
-1% -$3.65K ﹤0.01% 1226
2024
Q2
$239K Buy
5,936
+1,486
+33% +$62K ﹤0.01% 1268
2024
Q1
$158K Hold
4,450
﹤0.01% 1363
2023
Q4
$132K Sell
4,450
-1,600
-26% -$33.2K ﹤0.01% 1377
2023
Q3
$126K Hold
6,050
﹤0.01% 1438
2023
Q2
$148K Buy
6,050
+5,445
+900% +$175K ﹤0.01% 1399
2023
Q1
$25K Sell
605
-5
-0.8% -$207 ﹤0.01% 1943
2022
Q4
$27K Buy
610
+512
+522% +$23.2K ﹤0.01% 1969
2022
Q3
$5K Sell
98
-52
-35% -$2.85K ﹤0.01% 2304
2022
Q2
$9K Hold
150
﹤0.01% 2205
2022
Q1
$17K Sell
150
-25
-14% -$2.92K ﹤0.01% 2096
2021
Q4
$21K Buy
175
+25
+17% +$3.37K ﹤0.01% 1920
2021
Q3
$18K Hold
150
﹤0.01% 2118
2021
Q2
$15K Hold
150
﹤0.01% 2176
2021
Q1
$13K Hold
150
﹤0.01% 2181
2020
Q4
$14K Hold
150
﹤0.01% 2175
2020
Q3
$17K Hold
150
﹤0.01% 2059
2020
Q2
$15K Sell
150
-350
-70% -$27.9K ﹤0.01% 1837
2020
Q1
$32K Buy
500
+10
+2% +$701 ﹤0.01% 1626
2019
Q4
$29K Buy
490
+110
+29% +$6.78K ﹤0.01% 1631
2019
Q3
$22K Sell
380
-80
-17% -$5.11K ﹤0.01% 1629
2019
Q2
$30K Buy
460
+160
+53% +$10.3K ﹤0.01% 1564
2019
Q1
$19K Buy
+300
New +$15.8K ﹤0.01% 1625

Other funds holding TNDM

Nisa Investment Advisors's TNDM Position: Q2 2026 in Review

Nisa Investment Advisors reduced its Tandem Diabetes Care (TNDM) stake by 56% in Q2 2026, selling an estimated $27K and leaving 1,237 shares worth $18.7K. The position accounts for ﹤0.01% of the portfolio, ranked #2250.

Nisa Investment Advisors first reported a position in TNDM in Q1 2019 and has held it in 30 quarters since. The position peaked at $248K in Q3 2024. 274 funds tracked by Wall St. Rank hold TNDM as of Q2 2026.

  • Nisa Investment Advisors held 1,237 shares of Tandem Diabetes Care worth $18.7K as of Q2 2026.
  • Nisa Investment Advisors sold 1,545 Tandem Diabetes Care shares in Q2 2026, an estimated $27K.
  • Tandem Diabetes Care made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q2 2026, its #2250 holding.
  • Nisa Investment Advisors first reported a position in Tandem Diabetes Care in Q1 2019 and has held it in 30 quarters since.
  • Nisa Investment Advisors's Tandem Diabetes Care position peaked at $248K in Q3 2024.
  • 274 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2026.

Based on Nisa Investment Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.